These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32193549)

  • 1. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.
    Andrade P; Narvekar P; Montoya M; Michlmayr D; Balmaseda A; Coloma J; Harris E
    J Infect Dis; 2020 Jul; 222(4):590-600. PubMed ID: 32193549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.
    Andrade P; Coloma J; Harris E
    Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
    Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A
    J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika.
    Andrade P; Gimblet-Ochieng C; Modirian F; Collins M; Cárdenas M; Katzelnick LC; Montoya M; Michlmayr D; Kuan G; Balmaseda A; Coloma J; de Silva AM; Harris E
    Nat Commun; 2019 Feb; 10(1):938. PubMed ID: 30808875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection.
    Lyski ZL; Messer WB
    Front Immunol; 2019; 10():1276. PubMed ID: 31244836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.
    Michlmayr D; Andrade P; Nascimento EJM; Parker A; Narvekar P; Dean HJ; Harris E
    J Infect Dis; 2021 Feb; 223(2):247-257. PubMed ID: 32572472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1.
    Zambrana JV; Hasund CM; Aogo RA; Bos S; Arguello S; Gonzalez K; Collado D; Miranda T; Kuan G; Gordon A; Balmaseda A; Katzelnick LC; Harris E
    Sci Transl Med; 2024 May; 16(749):eadn2199. PubMed ID: 38809964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.
    Badolato-Corrêa J; Sánchez-Arcila JC; Alves de Souza TM; Santos Barbosa L; Conrado Guerra Nunes P; da Rocha Queiroz Lima M; Gandini M; Bispo de Filippis AM; Venâncio da Cunha R; Leal de Azeredo E; de-Oliveira-Pinto LM
    Immun Inflamm Dis; 2018 Jun; 6(2):194-206. PubMed ID: 29282904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
    Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection.
    Collins MH; McGowan E; Jadi R; Young E; Lopez CA; Baric RS; Lazear HM; de Silva AM
    Emerg Infect Dis; 2017 May; 23(5):773-781. PubMed ID: 28418292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
    Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
    Front Immunol; 2018; 9():2225. PubMed ID: 30327651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
    Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
    J Virol; 2020 May; 94(10):. PubMed ID: 32132233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human antibody response to Zika targets type-specific quaternary structure epitopes.
    Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.